Mechanistic basis for estrogenic effects in fathead minnow (Pimephales promelas) following exposure to the androgen 17alpha-methyltestosterone: conversion of 17alpha-methyltestosterone to 17alpha-methylestradiol.
Exposure of adult fathead minnows (Pimephales promelas) to the androgen 17alpha-methyltestosterone (MT) produces both androgenic and estrogenic effects, manifested as nuptial tubercle formation in females, and vitellogenin production in males and females, respectively. The present study was conducted to determine if the unanticipated estrogenic effects are produced by conversion of MT via aromatase activity to 17alpha-methylestradiol (ME2). Aromatase activity at the end of a 7-day waterborne MT exposure (20, 200microg/l) was significantly decreased in ovarian microsomes and brain homogenates from exposed fish, to about 30-50% of control activity. Although aromatase activity was decreased by 7 days, it is possible that the conversion of MT to ME2 occurred soon after initial exposure. In support of this, ME2 was detected in plasma samples of the fish following the 7-day exposure, confirming their ability convert the androgen MT to the estrogen ME2. The concentration of ME2 in plasma was within the range of plasma 17ss-estradiol (E2) found in control female fathead minnows (4-5ng/ml). These results, in conjunction with competitive binding assays that indicate ME2 binds to the fathead minnow estrogen receptor with a relative binding affinity of 68.3% of E2, support the hypothesis that aromatization of MT to ME2 contributes to the estrogenic effects in fathead minnows following exposure to this androgen.
Hornung
Michael W
MW
United States Environmental Protection Agency, Office of Research and Development, National Health and Environmental Effects Research Laboratory, Mid-Continent Ecology Division, Duluth, MN 55804, USA. hornung.michael@epa.gov
Jensen
Kathleen M
KM
Korte
Joseph J
JJ
Kahl
Michael D
MD
Durhan
Elizabeth J
EJ
Denny
Jeffrey S
JS
Henry
Tala R
TR
Ankley
Gerald T
GT
D000704:Analysis of Variance; D000818:Animals; D047072:Aromatase Inhibitors; D001667:Binding, Competitive; D003530:Cyprinidae / Q000378:metabolism / Q000502:physiology*; D004958:Estradiol / Q000031:analogs & derivatives* / Q000097:blood*; D005260:Female; D008297:Male; D008777:Methyltestosterone / Q000378:metabolism / Q000494:pharmacology*; D011960:Receptors, Estrogen / Q000378:metabolism; D012727:Sex Characteristics; D014819:Vitellogenins / Q000096:biosynthesis*
D047072:Aromatase Inhibitors; D011960:Receptors, Estrogen; D014819:Vitellogenins; C038254:17-methylestradiol; D004958:Estradiol; D008777:Methyltestosterone